Depot Medroxyprogesterone Acetate Use and the Development and Progression of Uterine Leiomyoma

OBJECTIVE: Investigate the association between use of depot medroxyprogesterone acetate (DMPA) (an injectable progestin-only contraceptive) and leiomyoma development. METHODS: We conducted a cohort study in the Detroit, Michigan, area that involved four clinic visits at 20-month intervals over 5 yea...

Descripción completa

Detalles Bibliográficos
Autores principales: Harmon, Quaker E., Patchel, Stacy A., Zhao, Shanshan, Umbach, David M., Cooper, Tracy E., Baird, Donna D.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2022
Materias:
Contents
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9015023/
https://www.ncbi.nlm.nih.gov/pubmed/35576339
http://dx.doi.org/10.1097/AOG.0000000000004745

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9015023/
https://www.ncbi.nlm.nih.gov/pubmed/35576339
http://dx.doi.org/10.1097/AOG.0000000000004745

Ejemplares similares